Skip to content
Explore the latest in technology, digital innovation, and s…

Zimbabwe Rejects ‘One-Sided’ US Health Aid Agreement Due to Data Apprehensions

Health funding illustration
The offered US financial assistance was intended for programmes for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a significant US healthcare agreement valued at $367m (£272m) spanning five years because of Washington's request for confidential information.

This rejection was revealed after a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".

An official representative has since explained that the US was demanding access to health data for scientific study and commercial gain while refused to share the benefits from future vaccines.

"We must now begin the challenging and unfortunate task of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has appealed for continued talks to secure a agreement acceptable to all parties so the country's critical HIV programme can be sustained.

Broader Implications

This rejection follows a comparable case in Kenya, where a high court suspended a related deal with the US following concerns were raised about the security of Kenyans' health data.

Since returning to office last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

USAID had administered assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and accountability.

Based on statements, Sixteen nations in Africa have to date signed these new health pacts, representing over $18.3bn in committed funds.

Details of the Declined Agreement

The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this collaboration could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," the Ambassador commented.

However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".

"Our nation was requested to surrender its biological resources and data over an extended period, with no equivalent promise of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," Mangwana explained.

"Effectively, our country would supply the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our citizens if a future pandemic emerge."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the global health body and its pursuit of one-on-one deals were undermining frameworks already established through the global health agency.

Mangwana cited its Pandemic Benefit-Sharing system created to manage potential global health emergencies.

"This system is designed to ensure that when a country provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to develop them."

The government's concerns over the US deal "must not be interpreted as opposition to America," he added.

"We encourage ongoing dialogue with our US partners on how subsequent co-operation could be arranged in a way that honours the independence and interests of both nations."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but urged that talks must proceed given that much of the country's HIV programmes were funded by foreign aid.

"In cases where technical issues exist, such as those involving information security or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," it said.

This impasse highlights the ongoing challenges between receiving much-needed foreign assistance and safeguarding a country's data in an ever more data-driven world.

By

Joseph Williams

Tech enthusiast and digital strategist with over a decade of experience in startup ecosystems and innovation trends.

MegaBlast

Type to search articles.